Table 1.
Baseline characteristics of patients with different types of hip replacements and matched controls (NJR cohort).
Table 2.
Bias-analysis: Relative rates of types of cancer (recorded in the CPRD)<six months after total hip replacement (recorded in NJR, stratified by bearing surface type), compared with matched controls without THR surgery, and patients with stemmed metal-on-metal total hip replacements (NJR cohort).
Table 3.
Relative rates of cancer (any type as recorded in the CPRD, HES or ONS) during the total follow-up period in patients with and without total hip replacements (as recorded in the CPRD, HES or NJR).
Table 4.
Cumulative incidence (%) of any cancer (as recorded in CPRD) after total hip replacement by bearing surface type, gender, and age categories gender, and age categories (NJR cohort).
Figure 1.
Crude RR of cancer over time in CPRD (and 95% CI) in patients with a metal-on-metal THR compared to patients with another bearing surface THR (as recorded in NJR).
Abbreviations: CI = confidence interval; CPRD = Clinical Practice Research Datalink; NJR = National Joint Registry.
Table 5.
Relative rates of types of cancer (as recorded in the CPRD) over time (CPRD cohort).